Anuradha (Anu) Ramamoorthy, PhD
Clinical Pharmacologist, OCP, CDER, FDA

Anu is a Clinical Pharmacologist in the Genomics and Targeted Therapy Group in the Office of Clinical Pharmacology (OCP), CDER, FDA. Anu contributes to regulatory review of investigational new drugs (IND), new drug applications (NDA), and biologic licensing applications (BLA) to effectively incorporate pharmacogenomic biomarker strategies during drug development. She manages regulatory science research projects focused on the use of genomic and other biomarkers in drug development, and is involved in regulatory policy and guidance development. She received Ph.D. in Genetics from Indiana University and has completed postdoctoral fellowships at NIA (NIH) and OCP (CDER, FDA).